Aurobindo Pharma Has one of many broadest API portfolios between Indian pharmaceutical corporations, with above two hundred APIs. It can be a leading world manufacturer of semi-artificial penicillins and maintains a robust presence in anti-retrovirals and cardiovascular APIs. The business’s vertically built-in product offers considerable Value advantages. Tilley has spent https://www.tjcy.com/industry-information/api-vs-fdf-vs-intermediates-what-s-the-difference.html